Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAbeona Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q2 2024 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q3 2024 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2024 | 3 | -$0.38 | -$0.31 | -$0.34 |
| Q1 2025 | 2 | -$0.36 | -$0.36 | -$0.36 |
| Q2 2025 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q3 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2025 | 1 | -$0.13 | -$0.13 | -$0.13 |
Abeona Therapeutics Inc. Earnings Date And Information
Abeona Therapeutics Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.31 earnings per share for the quarter, topping analysts' consensus estimates of $-0.38 by $0.07. The company had revenue of 0 for the quarter and had revenue of 3.50 M for the year. Abeona Therapeutics Inc. has generated $-3 earnings per share over the last year ($-2.53 diluted earnings per share) and currently has a price-to-earnings ratio of -3.84. Abeona Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Abeona Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.38 | -$0.63 | -0.25 | $100,000 | $0 |
| 08/12/2024 | Q2 2024 | -$0.33 | $0.19 | 0.52 | $100,000 | $0 |
| 05/15/2024 | Q1 2024 | -$0.47 | -$1.16 | -0.69 | $0 | |
| 03/18/2024 | Q4 2023 | -$0.51 | -$0.65 | -0.14 | $2.82 M | |
| 11/13/2023 | Q3 2023 | -$0.53 | -$0.48 | 0.05 | $0 | |
| 08/08/2023 | Q2 2023 | -$0.66 | -$0.92 | -0.26 | $3.50 M | |
| 05/11/2023 | Q1 2023 | -$0.58 | -$0.54 | 0.04 | $0 | |
| 04/10/2023 | Q4 2022 | $0.36 | $68,000 | |||
| 11/14/2022 | Q3 2022 | -$1.78 | -$1.48 | 0.3 | $0 | |
| 08/11/2022 | Q2 2022 | -$1.25 | -$1.23 | 0.02 | $1.00 M | |
| 05/13/2022 | Q1 2022 | -$2.00 | -$3.62 | -1.62 | $346,000 | |
| 03/31/2022 | Q4 2021 | -$11.15 | $3.00 M | |||
| 11/15/2021 | Q3 2021 | -$4.00 | -$1.80 | 2.2 | $0 | |
| 07/28/2021 | Q2 2021 | -$4.00 | -$3.93 | 0.07 | $0 | |
| 05/17/2021 | Q1 2021 | -$4.25 | $0 | |||
| 03/24/2021 | Q4 2020 | -$2.25 | -$4.26 | -2.01 | $3.00 M | |
| 11/09/2020 | Q3 2020 | -$3.25 | -$1.95 | 1.3 | $1.40 M | $7.00 M |
| 08/10/2020 | Q2 2020 | -$4.25 | -$3.51 | 0.74 | $0 | |
| 05/06/2020 | Q1 2020 | -$5.25 | -$13.04 | -7.79 | $0 | |
| 03/16/2020 | Q4 2019 | -$7.25 | -$4.43 | 2.82 | $0 |
Abeona Therapeutics Inc. Earnings: FAQ's
When is Abeona Therapeutics Inc.'s earnings date?
Abeona Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
Did Abeona Therapeutics Inc. beat their earnings estimates last
quarter?
In the previous quarter, Abeona Therapeutics Inc. (:ABEO) reported $-0.31 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.38 by $0.07.
How can I listen to Abeona Therapeutics Inc.'s earnings conference
call?
The conference call for Abeona Therapeutics Inc.'s latest earnings report can be listened to online.
How can I read Abeona Therapeutics Inc.'s conference call transcript?
The conference call transcript for Abeona Therapeutics Inc.'s latest earnings report can be read online.
How much revenue does Abeona Therapeutics Inc. generate each year?
Abeona Therapeutics Inc. (:ABEO) has a recorded annual revenue of $3.50 M.
How much profit does Abeona Therapeutics Inc. generate each year?
Abeona Therapeutics Inc. (:ABEO) has a recorded net income of $3.50 M. Abeona Therapeutics Inc. has generated $-2.53 earnings per share over the last four quarters.
What is Abeona Therapeutics Inc.'s price-to-earnings ratio?
Abeona Therapeutics Inc. (:ABEO) has a price-to-earnings ratio of -3.84 and price/earnings-to-growth ratio is 0.54.